Exagen inc. to participate in the william blair 43rd annual growth stock conference

San diego, may 30, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the william blair 43r d annual growth stock conference, which takes place june 6-8, 2023, in chicago at the loews chicago hotel. john aballi, exagen's president and chief executive officer, and kamal adawi, exagen's chief financial officer, will present on wednesday, june 7th, at 2:00 pm ct. interested parties may access the webcast of the presentation using a link on exagen's website at https://investors.exagen.com/events.
XGN Ratings Summary
XGN Quant Ranking